Skip to main content

Cost-effective reimbursement analysis for medical technologies in Europe

Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 34 EU countries

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Application window for the assessment of procedures and IVD tests now open in France

On May 17, 2024, the French National Authority for Health (HAS) announced the start of the application period for evaluating procedures and IVD tests to be included in the 2025 HAS working program.

Applications should concern registration, removal, or modification of registration conditions for services in the various nomenclatures (Common classification of medical acts (CCAM), General nomenclature of professional acts (NGAP), and Nomenclature of medical biology acts (NABM)). The requests must be made by the relevant National Professional Council (CNP) or an operator.

The application dossiers can be submitted only via the EVActe platform by September 12, 2024.

See the details in French here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.